Artru-Voegelé S, Sinniger V, Batandier C, Troprès I, Pellissier S, Bonaz B (2022) Contributions of hypnosis in Crohn’s disease management: interests and preliminary results of HypnoCrohn study. Hegel 12:199–212

Article  Google Scholar 

Badran BW, Yu AB, Adair D, Mappin G, DeVries WH, Jenkins DD, George MS, Bikson M (2019) Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. J Vis Exp 14310.3791/58984.

Ben-Horin S, Chowers Y (2011) Review article: loss of response to anti-TNF treatments in Crohn’s disease. Aliment Pharmacol Ther 33(9):987–995

Article  CAS  PubMed  Google Scholar 

Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC (2020a) Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 5(2):117–131

Article  PubMed  Google Scholar 

Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC (2020b) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 69(8):1441–1451

Article  PubMed  Google Scholar 

Bonaz B (2022) Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction. Neurogastroenterol Motil 34(10):e14456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144(1):36–49

Article  PubMed  Google Scholar 

Bonaz B, Picq C, Sinniger V, Mayol JF, Clarençon D (2013) Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 25(3):208–221

Article  CAS  PubMed  Google Scholar 

Bonaz B, Sinniger V, Hoffmann D, Clarençon D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocmé C, Faure P, Cracowski JL, Pellissier S (2016) Chronic vagus nerve stimulation in Crohn’s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil 28(6):948–953

Article  CAS  PubMed  Google Scholar 

Bonaz B, Sinniger V, Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 8:1452

Article  PubMed  PubMed Central  Google Scholar 

Bonaz B, Bazin T, Pellissier S (2018) The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front Neurosci 12:49

Article  PubMed  PubMed Central  Google Scholar 

Bonaz B, Sinniger V, Pellissier S (2021a) Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases. Front Neurosci 15:650971

Article  PubMed  PubMed Central  Google Scholar 

Bonaz B, Lane RD, Oshinsky ML, Kenny PJ, Sinha R, Mayer EA, Critchley HD (2021b) Diseases, Disorders, and Comorbidities of Interoception. Trends Neurosci 44(1):39–51

Article  CAS  PubMed  Google Scholar 

Boot WR, Simons DJ, Stothart C, Stutts C (2013) The Pervasive Problem With Placebos in Psychology: Why Active Control Groups Are Not Sufficient to Rule Out Placebo Effects. Perspect Psychol Sci 8(4):445–454

Article  PubMed  Google Scholar 

Brock C, Brock B, Aziz Q, Møller HJ, Pfeiffer Jensen M, Drewes AM, Farmer AD (2017) Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and Tumor necrosis factor-alpha. Neurogastroenterol Motil 29(5).

Brown DW, Anda RF, Tiemeier H, Felitti VJ, Edwards VJ, Croft JB, Giles WH (2009) Adverse childhood experiences and the risk of premature mortality. Am J Prev Med 37(5):389–396

Article  PubMed  Google Scholar 

Chan W, Chen A, Tiao D, Selinger C, Leong R (2017) Medication adherence in inflammatory bowel disease. Intest Res 15(4):434–445

Article  PubMed  PubMed Central  Google Scholar 

Chaparro M, Guerra I, Muñoz-Linares P, Gisbert JP (2012) Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease. Aliment Pharmacol Ther 35(9):971–986

Article  CAS  PubMed  Google Scholar 

Click B, Regueiro M (2019) Managing risks with biologics. Curr Gastroenterol Rep 21(2):1

Article  PubMed  Google Scholar 

Dent E, Davinson N, Wilkie S (2022) The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Appl Psychol Health Well Being 14(2):626–644

Article  PubMed  Google Scholar 

Devenney J, Hasan SS, Morris J, Whorwell PJ, Vasant DH (2024) Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis. Aliment Pharmacol Ther 59(2):269–277

Article  PubMed  Google Scholar 

D'Haens G, Eberhardson M, Cabrijan Z, Danese S, van den Berg R, Löwenberg M, Fiorino G, Schuurman PR, Lind G, Almqvist P, Olofsson PS, Tracey KJ, Hanauer SB, Zitnik R, Chernoff D, Levine YA (2023) Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study. J Crohns Colitis Sep 21:jjad151.

Drewes AM, Brock C, Rasmussen SE, Møller HJ, Brock B, Deleuran BW, Farmer AD, Pfeiffer-Jensen M (2021) Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study. Scand J Rheumatol 50(1):20–27

Article  CAS  PubMed  Google Scholar 

Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L (2018) Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome foundation working team report. Gastroenterology 154(4):1140–1171

Article  PubMed  Google Scholar 

Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M (2017) Involvement of CRF2 signaling in enterocyte differentiation. World J Gastroenterol 23(28):5127–5145

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC (2020) Prevalence of irritable bowel syndrome type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5(12):1053–1062

Article  PubMed  Google Scholar 

Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ (2019) Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 4(1):20–31

Article  PubMed  Google Scholar 

Ford AC, Moayyedi P (2010) Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 32(2):144–158

Article  CAS  PubMed  Google Scholar 

Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA, ATLANTIS trialists, (2023) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402(10414):1773–1785

Article  CAS  PubMed  Google Scholar 

Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S (2020) Interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome. Front Psychiatry 11:229

Article  PubMed  PubMed Central  Google Scholar 

Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB (2023) A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sci Sep 13(9):1305.

Go YY, Ju WM, Lee CM, Chae SW, Song JJ (2022) Different transcutaneous auricular vagus nerve stimulation parameters modulate the anti-inflammatory effects on lipopolysaccharide-induced acute inflammation in mice. Biomedicines 10(2):247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Godoy LC, Frankfurter C, Cooper M, Lay C, Maunder R, Farkouh ME (2021) Association of adverse childhood experiences with cardiovascular disease later in life: a review. JAMA Cardiol 6(2):228–235

Article  PubMed  Google Scholar 

Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ (2003) Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut 52(11):1623–1629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gwee KA (2010) Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other ibs and functional dyspepsia. J Neurogastroenterol Motil 16(1):30–34

Article  PubMed  PubMed Central  Google Scholar 

Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM (2023) Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. World J Gastroenterol 29(20):3185–3202

Article  PubMed  PubMed Central  Google Scholar 

Hasan SS, Pearson JS, Morris J, Whorwell PJ (2019) Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment. Int J Clin Exp Hypn 67(1):69–80

Article  PubMed  PubMed Central  Google Scholar 

Hasan SS, Whorwell PJ, Miller V, Morris J, Vasant DH (2021) Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology 160(7):2605-2607.e3

Article  PubMed  Google Scholar 

Jänig W, Khasar SG, Levine JD, Miao FJ (2000) The role of vagal visceral afferents in the control of nociception. Prog Brain Res 122:273–287

Article  PubMed  Google Scholar 

Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S (2024) Withdrawal of immunomodulators or TNF antagonists in patients with inflammatory bowel diseases in remission on combination therapy: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 22(1):22-33.e6

Article